Insights: News Releases Kilpatrick Townsend Adds Healthcare Government Relations Counsel in Washington, D.C.
Cybil G. Roehrenbeck Joins Firm
WASHINGTON, D.C. (January 13) – Kilpatrick Townsend & Stockton announced today that Cybil Roehrenbeck has joined the firm’s Washington, D.C. office, adding to its Government Relations and Healthcare, Life Sciences & Technology Practices.
“We welcome Cybil to the firm,” said Henry Walker, Kilpatrick Townsend Chair. “Her experience working with government agencies and legislators on healthcare, life sciences and technology issues deepens both our Government Relations and our Healthcare, Life Sciences & Technology practices. Cybil’s addition reflects the firm’s commitment to these practice areas and is key to providing our clients with outstanding resources.”
Prior to joining the firm, Ms. Roehrenbeck was Assistant Director and Counsel in the Division of Federal Affairs of the American Medical Association (AMA) in Washington, D.C., as well as Washington Counsel in the AMA’s Division of Legislative Counsel. Ms. Roehrenbeck led advocacy campaigns to impact federal policy in the areas of healthcare fraud and abuse (including Stark, False Claims Act, and Anti-kickback regulation); hospital practice; clinical integration and antitrust; healthcare services reimbursement; and innovative healthcare technologies. She also garnered extensive experience in securing amendments to federal rules and policies and seeking agency clarification to the same. Ms. Roehrenbeck previously served as Counsel and Legislative Assistant to Walter B. Jones (R-NC) in the U.S. House of Representatives and as an Associate with J.C. Watts Companies LLC.
Ms. Roehrenbeck’s practice at Kilpatrick Townsend will focus on providing strategic legal counsel to healthcare providers, companies, and innovators on the emerging legal and regulatory landscape pursuant to the Affordable Care Act and developing market trends. She will provide counsel to entities in the healthcare services, technology, and pharmaceutical industries on effective government relations strategies with federal agencies and Congress, as well as regulatory troubleshooting and compliance.
Ms. Roehrenbeck will also assist clients with outreach to federal agencies and Congress in regard to healthcare services reimbursement, compliance, audit investigations, and competition matters. She will work with firm clients to ensure that federal policymakers understand their values, challenges, and interests; to seek clarification or amendment to federal rules and policies impacting their business; and to shepherd these healthcare stakeholders through federal agencies and procedures.
Ms. Roehrenbeck received her J.D. from the University of Georgia School of Law and B.A. in Politics and English from the University of Virginia.
“Having previously worked with attorneys at Kilpatrick Townsend, I am honored to be joining a firm of its caliber of client service and knowledgebase.” said Cybil Roehrenbeck. “I look forward to working closely with the entire Kilpatrick team to bring value to clients in the healthcare, life sciences and technology industries.”
For more information about Kilpatrick Townsend, please visit: www.kilpatricktownsend.com.
Follow the firm on Twitter: @KTS_Law.
###
Related Industries
Disclaimer
While we are pleased to have you contact us by telephone, surface mail, electronic mail, or by facsimile transmission, contacting Kilpatrick Townsend & Stockton LLP or any of its attorneys does not create an attorney-client relationship. The formation of an attorney-client relationship requires consideration of multiple factors, including possible conflicts of interest. An attorney-client relationship is formed only when both you and the Firm have agreed to proceed with a defined engagement.
DO NOT CONVEY TO US ANY INFORMATION YOU REGARD AS CONFIDENTIAL UNTIL A FORMAL CLIENT-ATTORNEY RELATIONSHIP HAS BEEN ESTABLISHED.
If you do convey information, you recognize that we may review and disclose the information, and you agree that even if you regard the information as highly confidential and even if it is transmitted in a good faith effort to retain us, such a review does not preclude us from representing another client directly adverse to you, even in a matter where that information could be used against you.